Molecular Partners FY EPS $(1.81) Up From $(2.13) YoY, Sales $5.65M Down From $7.89M YoY

Molecular Partners (NASDAQ:MOLN) reported quarterly losses of $(1.81) per share. This is a 15.1 percent increase over losses of $(2.13) per share from the same period last year. The company reported $5.65 million in sales this quarter. This is a 28.46 percent decrease over sales of $7.89 million the same period last year.